The net worth of the total cardiopulmonary bypass systems sold globally was estimated to be around USD 173.9 million back in the year 2018.
The global cardiopulmonary bypass system market is forecasted to be appraised at USD 270.9 million by 2033, up from USD 197.3 million in 2023, advancing at a CAGR of 3.2% during the forecast period.
The rising healthcare expenditure to curb serious illnesses, such as cardiac diseases, is estimated to drive the demand for cardiopulmonary bypass systems.
However, adverse side effects as a result of bypass procedures are likely to curb the adoption of these systems. Conversely, the fast-growing technological developments and increasing count of surgical procedures are expected to stimulate market advancement and issue creative options for market players.
The roller cardiopulmonary bypass pumps in the overall market share are likely to expand owing to their advantages. These include lower costs, simplicity, ease of use, reliability of flow calculation, and increased resistance without reducing flow.
Primary or secondary pulmonary hypertension is growing in lung transplantation procedures. The systems have witnessed an increasing penetration in en-bloc double-lung transplantation. These factors are likely to greatly contribute to the market's key trends and opportunities.
Due to continual monitoring of line or circuit pressure, temperature, blood parameters, and safety features, modern cardiopulmonary bypass systems are increasingly being used in hospitals. Furthermore, a growth in cardiovascular procedures are increasing product penetration and is anticipated to bolster the total market growth.
| Report Attributes or Data Points | Details |
|---|---|
| Global Cardiopulmonary Bypass System Market Valuation in 2022 | USD 192.4 million |
| Estimated Global Market Share in 2023 | USD 197.3 million |
| Forecasted Global Market Size by 2033 | USD 270.9 million |
| Projected Global Market Growth Rate from 2023 to 2033 | 3.2% CAGR |
| Historical Market Growth Rate from 2018 to 2022 | 2% CAGR |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
One of the most pivotal drivers that govern the acceleration of the global market share is the growing geriatric population. Moreover, the increase in the prevalence of cardiovascular diseases, such as supraventricular tachycardia, atrial fibrillation, atrial flutter, etc., surges a serious demand for cardiopulmonary bypass.
Due to changing lifestyles, a lot of cardiac issues come into question. These include a decrease in heart muscle elasticity or a decrease in heart output. These concerns demand the rapid deployment of cardiopulmonary bypass systems.
Unhealthy dietary habits coupled with a lack of proper exercise practiced for a prolonged period can increase the occurrences of heart-related diseases, such as heart failure. These factors are likely to propel the demand and boost the cardiopulmonary bypass system market size.
Sedentary lifestyles and increasing stress issues due to extensive workload can negatively impact the heart in the long run. These factors, along with an increase in organ transplant surgeries, are likely to surge the deployment of cardiopulmonary bypass systems eventually.
The cardiopulmonary bypass systems market has witnessed stringent government regulations, which is a key challenge, along with the recall of the components of cardiopulmonary bypass equipment. Additionally, a shortage of skilled professionals able to perform heart- or lung-related procedures is likely to obstruct the growth of the market.
Rising cases of cardiac illnesses are increasing the awareness of the benefits of cardiopulmonary bypass systems, which is likely to generate lucrative opportunities for the market and secure its advancement. Moreover, medical tourism growing in popularity is expected to create numerous scopes for manufacturers and increase sales of the cardiopulmonary bypass system.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| North America | 37.2% |
| Europe | 27.3% |
North America is the leading market, with a significant revenue share of 30.6% in 2022. This is attributed to the high healthcare infrastructure and favorable reimbursement scenario.
Increasing technological development of cardiopulmonary bypass accessory equipment, owing to the presence of the largest customer base with high GDP, is estimated to contribute to the market growth significantly. Furthermore, rising cases of cardiovascular diseases in this region are likely to further contribute to the expansion of the overall market size.
| Regional Market Comparison | Global Market Share in Percentage |
|---|---|
| United States | 33.5% |
| Germany | 5.8% |
| Japan | 3.6% |
Chronic cardiovascular cases are rising across the globe and require improved surgical procedures. Manufacturers are incorporating contemporary strategies to enhance their presence in the market. This includes adopting both organic and inorganic growth strategies, such as acquisitions and new product launches, to garner a higher market share.
Start-up companies are applying their strategies to contribute to market growth. This is likely to advance their presence in the market, as well as improve cardiovascular disease treatments.
Ventura Medical is developing a catheter-based heart pump to provide cardiac support to patients in need of cardiopulmonary support. According to Venstra Medical, the temporary device may allow cardiologists to provide patients in need of cardiac support with a treatment option that does not require surgical intervention.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 2.3% |
| China | 3.9% |
| India | 3.2% |
| Australia | 2.8% |
Key manufacturers are primarily focusing on providing innovative products to various hospitals through collaborative relationships or mergers. This is because this market is especially technology-driven and is strengthened by constant product innovations.
Key market participants of the cardiopulmonary bypass system market:
| Category | By Product Type |
|---|---|
| Top Segment | Conventional |
| Market Share in Percentage | 63.8% |
| Category | By End User |
|---|---|
| Top Segment | Hospital |
| Market Share in Percentage | 44.7% |
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Some Recent Developments in the Cardiopulmonary Bypass System Market are:
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 3.2% from 2022 to 2032 |
| The base year for estimation | 2022 |
| Historical data | 2018 to 2022 |
| Forecast period | 2023 to 2033 |
| Quantitative units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors and trends, Pricing Analysis, |
| Segments Covered | Product Type, Modality, End User, and Region. |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia, and New Zealand |
| Country scope | USA; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; United Arab Emirates; Iran; South Africa |
| Key companies profiled | LivaNova PLC (Sorin Group), Abbott Laboratories, Braile Biomedica, Spectrum Medical, Minnetronix Inc., Transonic, Medtronic plc., MAQUET Holding B.V. & Co. KG, Getinge AB, Terumo Corporation, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, Eurosets Srl, OriGen Biomedical, Thoratec Corporation, Tianjin Medical, Olympus Corporation, Haemonetics Corporation, etc. |
| Customization scope | Free report customization (equivalent to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The market in 2023 is valued at USD 197.3 million.
The market will reach USD 270.9 million by 2033.
The market will register a 3.2% CAGR until 2033.
From 2018 to 2022, the market expanded at a 2% CAGR.
Minnetronix Inc., Transonic, and MAQUET Holding B.V. & Co. KG are some key players.
| Market Estimated Value (2023) | USD 1.37 billion |
|---|---|
| Market Estimated Value (2033) | USD 2.48 billion |
| Market Value CAGR (2023 to 2033) | 6.1% |
| Estimated Market Value (2022) | USD 13.9 Billion |
|---|---|
| Estimated Market Value (2032) | USD 21.6 Billion |
| CAGR (2022 to 2032) | 4.5 % |
Explore Therapeutic Device Insights
View Reports
Cardiopulmonary Bypass System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
